Okta ($OKTA) Insider Trading & Smart Money Activity

Okta, Inc. · Software - Infrastructure · Latest filing Oct 14, 2026

Okta, Inc. ($OKTA) has 22 insider trades, 2 congress trades, 1 13F position change and 30 analyst ratings on file. In the last 12 months on the open market, no insider bought and 4 insiders sold ($14.11M), net -$14.11M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
4
Net insider $ (12 mo)
-$14.11M
Congress trades (12 mo)
2
13F moves on file
1
Analyst ratings on file
30

OKTA insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $295.56K 0 / 0 0 / 0
Q3 2026 0 2 · $10.62M 1 / 1 0 / 0
Q4 2026 0 2 · $3.20M 0 / 0 0 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All OKTA insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F DAVENPORT Reduced -431.27K sh $78.12M Read
Analyst BMO Capital Reiterates to Outperform PT $245 -19.3% Read
Insider Ninan ShibuChief Accounting Officer Sell (Open-market sale) 10b5-1 2K sh $440.44K -5.3% —
Insider Ninan ShibuChief Accounting Officer Sell (Open-market sale) 10b5-1 12.68K sh $2.76M -2.8% —
Analyst Morgan Stanley Reiterates to Overweight PT $245 +6.7% —
Analyst Scotiabank Reiterates to Sector Outperform PT $245 +8.0% —
Analyst Citizens Reiterates to Market Outperform PT $225 +8.0% —
Analyst Truist Securities Reiterates to Buy PT $235 +8.4% —
Analyst Stephens Reiterates to Overweight PT $240 +8.4% —
Analyst Macquarie Reiterates to Outperform PT $240 +8.4% —
Analyst BMO Capital Reiterates to Outperform PT $230 +8.4% —
Analyst Baird Reiterates to Outperform PT $235 +8.4% —
Analyst Wells Fargo Reiterates to Overweight PT $230 +2.9% —
Analyst Stifel Reiterates to Buy PT $215 +2.9% —
Analyst Roth Capital Reiterates to Buy PT $235 +2.9% —
Analyst RBC Capital Reiterates to Outperform PT $230 +2.9% —
Congress Maria Elvira Salazar Sale $1,001 - $15,000 +2.9% Read
Analyst Oppenheimer Reiterates to Outperform PT $227 +2.9% —
Analyst Needham Reiterates to Buy PT $230 +2.9% —
Analyst Jefferies Reiterates to Buy PT $240 +2.9% —
Analyst Guggenheim Reiterates to Buy PT $227 +2.9% —
Analyst Evercore ISI Group Reiterates to Outperform PT $240 +2.9% —
Analyst DA Davidson Reiterates to Buy PT $235 +2.9% —
Analyst BTIG Reiterates to Buy PT $219 +2.9% —
Analyst Barclays Reiterates to Overweight PT $215 +2.9% —
Analyst Scotiabank Reiterates to Sector Outperform PT $190 +4.2% —
Insider McKinnon ToddChief Executive Officer Sell (Open-market sale) 10b5-1 48.82K sh $9.45M +4.2% —
Analyst Baird Reiterates to Outperform PT $200 +4.2% —
Analyst Needham Reiterates to Buy PT $230 +5.7% —
Insider Kelleher Eric RobertPresident and Chief Operating Officer Sell (Open-market sale) 10b5-1 6.39K sh $1.17M +7.0% —
Analyst BTIG Reiterates to Buy PT $219 +8.7% —
Analyst Bernstein Lowers to Market Perform PT $174 +8.7% —
Congress Maria Elvira Salazar Purchase $1,001 - $15,000 -2.4%+28.0% Read
Analyst Keybanc Reiterates to buy PT $130 +18.6%+15.2% Read
Analyst BTIG Reiterates to buy PT $136 +18.6%+15.2% Read
Analyst Needham Reiterates to buy PT $140 +18.5%+16.8% Read
Insider Larissa SchwartzChief Legal Officer and Corporate Secretary Sell (Open-market sale) 10b5-1 2.46K sh $295.56K +13.3%+17.9% —
Insider Bates Anthony John Sell (Option exercise) 2.03K sh +13.3%+22.2% —
Insider Bates Anthony John Buy (Option exercise) 2.03K sh +13.3%+22.2% —
Insider David Schellhase Buy (Grant or award) 2.08K sh +1.2%+26.0% Read
Insider Paul Sagan Buy (Grant or award) 2.08K sh +1.2%+26.0% Read
Insider Kerrest Jacques Frederic Sell (Gift) 6.80K sh +1.2%+26.0% —
Insider Kerrest Jacques Frederic Buy (Grant or award) 2.08K sh +1.2%+26.0% Read
Insider Emilie Choi Buy (Grant or award) 2.08K sh +1.2%+26.0% Read
Insider Bates Anthony John Buy (Grant or award) 2.08K sh +1.2%+26.0% Read
Insider Kerrest Jacques Frederic Sell (Option exercise) 2.49K sh +4.9%+32.1% —
Insider Kerrest Jacques Frederic Buy (Option exercise) 2.49K sh +4.9%+32.1% —
Insider Shibu NinanChief Accounting Officer Sell (Gift) 2.49K sh +1.6%+27.1% —
Insider Brett TigheChief Financial Officer Buy (Option exercise) 12.01K sh -1.8%+27.7% Read
Insider Todd MckinnonChief Executive Officer Sell (Tax withholding) 10.71K sh -1.8%+27.7% Read
Insider Todd MckinnonChief Executive Officer Buy (Option exercise) 21.05K sh -1.8%+27.7% Read
Insider Kelleher Eric RobertPresident and Chief Operating Officer Sell (Tax withholding) 8.29K sh -1.8%+27.7% Read
Insider Addison Jonathan JamesChief Revenue Officer Sell (Option exercise) 12.74K sh -1.8%+27.7% Read
Insider Addison Jonathan JamesChief Revenue Officer Buy (Option exercise) 12.74K sh -1.8%+27.7% Read
Analyst UBS Reiterates to buy PT $150 -3.1%+24.1% —

1W / 1M / 6M = how OKTA moved from the trade or filing date.

Insider trading in OKTA: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Ninan Shibu Chief Accounting Officer 2 -$3.20M Oct 8, 2026
McKinnon Todd Chief Executive Officer 1 -$9.45M Sep 22, 2026
Kelleher Eric Robert President and Chief Operating Officer 2 -$1.17M Sep 18, 2026
Larissa Schwartz Chief Legal Officer and Corporate Secretary 1 -$295.56K Jun 22, 2026
Bates Anthony John 3 — Jun 21, 2026
Kerrest Jacques Frederic 4 — Jun 18, 2026
David Schellhase 1 — Jun 18, 2026
Paul Sagan 1 — Jun 18, 2026
Emilie Choi 1 — Jun 18, 2026
Shibu Ninan Chief Accounting Officer 1 — Jun 16, 2026
Todd Mckinnon Chief Executive Officer 2 — Jun 15, 2026
Addison Jonathan James Chief Revenue Officer 2 — Jun 15, 2026
Brett Tighe Chief Financial Officer 1 — Jun 15, 2026

Members of Congress trading OKTA

Institutions moving OKTA (13F)

Analyst ratings on OKTA

DateFirmActionRatingPrice target1W1M6MStory
BMO Capital Reiterates Outperform $230 → $245 -19.3% Read
Morgan Stanley Reiterates Overweight $200 → $245 +6.7% —
Scotiabank Reiterates Sector Outperform $190 → $245 +8.0% —
Citizens Reiterates Market Outperform $180 → $225 +8.0% —
Truist Securities Reiterates Buy $200 → $235 +8.4% —
Stephens Reiterates Overweight $190 → $240 +8.4% —
Macquarie Reiterates Outperform $185 → $240 +8.4% —
BMO Capital Reiterates Outperform $187 → $230 +8.4% —
Baird Reiterates Outperform $200 → $235 +8.4% —
Wells Fargo Reiterates Overweight $200 → $230 +2.9% —

Frequently asked questions

Are OKTA insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 4 insiders made 5 open-market sales worth $14.11M, a net -$14.11M.

What is the latest insider trade in OKTA?

Ninan Shibu, Chief Accounting Officer filed a sell (open-market sale) of 2K sh worth $440.44K on Oct 8, 2026.

Which members of Congress traded OKTA?

2 disclosed trades by Maria Elvira Salazar. The latest was on Sep 24, 2026.

Which institutions changed their OKTA positions?

Recent 13F filers moving the stock include DAVENPORT.

Other software - infrastructure stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text